Could a Cholesterol-Lowering cream replace surgery for eyelid bumps?
NCT ID NCT07662785
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a cream containing simvastatin (a cholesterol-lowering drug) can safely shrink yellow cholesterol deposits on the eyelids, called xanthelasma. Thirty adults will apply either the active cream or a placebo nightly for 24 weeks, then everyone gets the active cream for another 24 weeks. The goal is to see if this non-invasive option works without the scarring or recurrence risks of current treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Topical simvastatin 2% cream
- What this could lead to
- If it works, this could offer a non-invasive, scar-free treatment for xanthelasma, replacing surgery or lasers.
- What could go wrong
- This is a small, early-phase pilot study with only 30 participants. The cream may not shrink the deposits, or could cause irritation. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for XANTHELASMA PALPEBRARUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.